Request for the Approval of Denosumab to Protect Bones in Men with Advanced Prostate Cancer

Amgen has submitted a supplemental Biologics License Application (sBLA) to the FDA to expand the indication for denosumab (XGEVA) its RANK ligand inhibitor to treat men with castrate-resistant prostate cancer to reduce the risk of developing bone metastases. Although some doctors have already begun to use Xgeva in men with advanced prostate cancer, it is [...]

On the Horizon – Denosumab (Xgeva) to Slow the Development of Bone Mets

Amgen has submitted a supplemental Biologics License Application (sBLA) to the FDA to expand the indication for denosumab (XGEVA) its RANK ligand inhibitor to treat men with castrate-resistant prostate cancer to reduce the risk of developing bone metastases. If approved, denosumab would be the first therapy licensed to prevent or delay the spread of cancer [...]

Some Great News For Our European Brothers In Their Fight Against Advanced Prostate Cancer

Things are looking up for our European readers. It must be frustrating for people outside of the United States to read this blog and learn about the many advances we now have in the US which are not available to them. The good news is that Sanofi has just launched Jevtana (cabazitaxel) in the UK [...]

From A Recent Post I Made on the AdvancedProstateCancer Support Group

My personal belief is what does it matter since all of our goals really should be finding ways to live our lives to the fullest, gain all possible life extensions while also maintaining a decent quality of life. There are things that are just out of our personal control, those we just need to accept. [...]

Go to Top